Business Context and Reporting Period
This Form 8-K filing by TRIMAS CORPORATION (TRS) was submitted on June 3, 2025. The report discloses a significant change in executive leadership, specifically the appointment of a new President and Chief Executive Officer (CEO) and the transition of the current CEO to an advisory role.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
- Leadership Transition: The Board appointed Mr. Thomas Snyder as President and CEO, effective June 23, 2025. He succeeds Mr. Thomas Amato.
- Board Membership: Mr. Snyder was also appointed to the Board of Directors, effective June 23, 2025.
- Outgoing CEO Role: Mr. Thomas Amato will transition to a non-executive role as Special Advisor to assist with the transition until June 30, 2025.
Compensation, Outlook, and Risks
Compensation Package for Mr. Snyder
- Base Salary: $800,000 annually.
- 2025 Bonus: Lump-sum cash bonus of $400,000 (payable in early 2026).
- Short-Term Incentive (STI): Target of 100% of base salary (range 0% to 200%), starting in 2026.
- Equity Awards (Inducement):
- Approximately $4.25 million in time-based Restricted Stock Units (RSUs), vesting over three years.
- Approximately $6.0 million in premium-priced stock options, vesting over five years across five tranches with exercise prices ranging from $30 to $50 per share.
- Relocation and Benefits: Up to $450,000 relocation allowance, $35,000 legal expense reimbursement, and 90 days of commuting expense reimbursement.
Severance Arrangements
- Standard Involuntary Termination: 1x (Base Salary + Target STI) plus pro-rated STI and 12 months of health coverage.
- Change in Control (within 2 years): 2x (Base Salary + Target STI) plus pro-rated STI and 24 months of health coverage.
- Conditions: Payments are subject to a release of claims and the Company's clawback policy.
Risks and Contingencies
The appointment is subject to customary pre-employment conditions. The equity awards are contingent on Mr. Snyder commencing employment and comply with Nasdaq Listing Rule 5635(c)(4). The filing notes standard non-competition and non-solicitation covenants.
Investor Verification Checklist
- Verify the exact commencement date of Mr. Snyder's employment (currently set for June 23, 2025, or earlier by agreement).
- Confirm the final closing price of TRS stock on the grant date to validate the premium exercise prices of the stock options.
- Review the specific terms of the "good reason" and "cause" definitions in the Offer Letter and Severance Agreement.
- Monitor the transition period ending June 30, 2025, to ensure Mr. Amato's advisory role concludes as scheduled.